Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q4 EPS of ($0.82), $0.17 better than the analyst estimate of ($0.99).

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.